Answers are grounded in this paper and cite their sources.
Differentiating radiation necrosis (RN) from tumor progression (TP) after radiation therapy for brain metastases is an important clinical problem requiring advanced imaging techniques that may not be widely available and are challenging to perform at multiple time points. The ability to leverage conventional MRI for this problem could have a meaningful clinical impact. The purpose of this study was to explore contrast-enhanced T2 FLAIR (T2FLAIRc) as a new imaging biomarker of RN and TP.
No takes yet. Share an insight, caveat, or question.
Heyn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: